| Serial Number | 87975639 |
| Word Mark | NAVICAN |
| Filing Date | Thursday, June 30, 2016 |
| Status | 710 - CANCELLED - SECTION 8 |
| Status Date | Friday, March 29, 2024 |
| Registration Number | 5292993 |
| Registration Date | Tuesday, September 19, 2017 |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, November 8, 2016 |
| Goods and Services | Pharmaceutical benefit management services; insurance claims processing in the field of diagnostics and pharmaceutical claims; providing a database featuring information and statistics about patient reimbursement and insurance coverage for diagnostics and pharmaceuticals; and reimbursement payment processing in the field of diagnostics and pharmaceutical claims; and providing information in the field of financial support options and resources for prescribers, patients and the pharmaceutical industry; providing patient reimbursement and insurance coverage information in the field of drug reimbursement for prescribers, patients and the pharmaceutical industry; providing patient reimbursement and insurance coverage information in the field of diagnostics reimbursement for providers and patients; financial administration of diagnostics and pharmacy reimbursement programs and services |
| Goods and Services | Pharmaceutical procurement services, namely, purchasing pharmaceuticals for others; pharmaceutical cost management services and drug utilization review services; assisting patients in enrolling in diagnostics and pharmaceutical reimbursement programs of others; providing business, pricing, reimbursement benchmarking and other market intelligence information in the field of drug reimbursement for prescribers, patients and the pharmaceutical industry; providing business, pricing, reimbursement benchmarking and other market intelligence information in the field of diagnostics reimbursement for providers and patients; business administration of diagnostics and pharmacy reimbursement programs and services; business management and consultation services in the field of specialty pharmacy, namely, assisting patients and providers with pharmaceutical reimbursement; business management and consultation services in the field of off label pharmaceuticals, namely, assisting patients and providers with pharmaceutical reimbursement; business management services in the field of diagnostics, namely, assisting patients and providers with diagnostics reimbursement; and promoting collaboration within the scientific, research and medical communities to achieve advances in the fields of healthcare and pharmaceuticals; business management of comprehensive programs involving drug therapy |
| Goods and Services | Dispensing of pharmaceuticals; medical and pharmaceutical consultation; pharmaceutical advice; pharmaceutical compounding services; providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals; medical services, namely, providing personalized drug therapy management programs to cancer patients based on the patient's genetic testing results; genetic testing for medical purposes; genetic testing for cancer diagnosis, treatment and prevention purposes; providing genetic sequencing and consulting services via website designed to provide cancer patients and oncologists with custom tailored information about the range of possible treatments and drug therapies for a particular cancer; providing information to patients and physicians via a website to recommend cancer treatment and drug therapies based on the patient's genetic testing results; providing personalized drug therapy services for cancer patients; drug utilization review dispensing services via a website, namely, identifying cancer drug therapies based on a patient's genetic testing results prior to dispensing medications; developing and managing comprehensive treatment programs involving drug therapy; physician support services in the nature of providing consultation in the dispensing of prescription drugs for persons with particular cancers; providing medical evaluations of patients to determine acceptability for participation in clinical trials; providing healthcare counseling, screening, diagnosis, prognosis, treatment, relapse, palliative, integrative medicine, survivorship, and other related medical information in the field of oncology; providing a database in the field of oncology and featuring inputting and collection of data and information all for treatment and diagnosis purposes; healthcare consultation in the field of cancer treatment research, namely, advising patients on cancer treatment research studies in which they might participate for purposes of treating their conditions; providing an online searchable database in the fields of oncolology, bioinformatics, clinical information technology, genomic data and genomic sequence analysis for personalized diagnosis, treatment and prevention of cancer |
| Goods and Services | Medical, clinical and scientific research in the field of oncology, namely, research relating to genetic diagnostic assays and pharmaceuticals for personalized diagnosis, treatment and prevention of cancer; scientific and technological services, namely, research services for medical purposes in the field of genetic diagnostic assays and pharmaceuticals research for personalized diagnosis, treatment and prevention of cancer; providing medical and scientific research information and scientific consulting in the field of genetic diagnostic assays and pharmaceuticals for diagnosis, treatment and prevention of cancer; conducting early evaluations in the field of new genetic diagnostics assays and pharmaceuticals; development, evaluation and medical and scientific research of genetic diagnostic assays for personalized diagnosis, treatment and prevention of cancer; laboratory research services relating to genetic diagnostic assays for personalized diagnosis, treatment and prevention of cancer; providing medical and scientific research information in the field of genetic diagnostic assays, pharmaceuticals, clinical trials and genetics; technical consulting related to scientific and medical studies in the field of genetic diagnostic assay and pharmaceuticals for personalized diagnosis, treatment and prevention of cancer; basic and clinical research in the field of oncology, namely, researching genetic diagnostic assays and pharmaceuticals for personalized diagnosis, treatment and prevention of cancer; providing medical and scientific research information in the field of genetic diagnostic assays, pharmaceuticals and clinical trials for personalized diagnosis, treatment and prevention of cancer; custom design and development of chemical reagants and multiplex sequencing assays for personalized diagnosis, treatment and prevention of cancer; providing an on-line computer database featuring medical and scientific research information in the field of oncology that allows for input and collection of scientific and research data and information relating to genetic diagnostic assays and pharmaceuticals for diagnosis, treatment and prevention of cancer; data collection for research purposes, namely, data mining and pattern recognition, designing clinical studies, and generating genomic data from patient samples for personalized diagnosis, treatment and prevention of cancer; data collection for research purposes, namely, the collection and systematic sorting of clinical and patient data comprising patient specific clinical data and scientific clinical studies relating to genetic diagnostic assays and pharmaceuticals for personalized diagnosis, treatment and prevention of cancer; data collection for research purposes, namely, the collection of mathematical and statistical data, clinical data, patient data and data of clinical studies relating to clinical response to cancer treatments for personalized diagnosis, treatment and prevention of cancer; compiling data for research purposes in the field of medical science, namely, compiling patient specific molecular and genomic data, patient specific clinical data and scientific clinical studies for personalized diagnosis, treatment and prevention of cancer; providing a website featuring technology with a web-based interface where medical professionals can view genetic test results and interpretations of the results by scientists and medical professionals in the field of genomics, and select the appropriate treatment and order the necessary pharmaceutical products |
| International Class | 035 - Advertising; business management; business administration; office functions. |
| US Class Codes | 100, 101, 102 |
| Class Status Code | 2 - Sec. 8 - Entire Registration |
| Class Status Date | Friday, March 29, 2024 |
| Primary Code | 035 |
| First Use Anywhere Date | Friday, May 12, 2017 |
| First Use In Commerce Date | Friday, May 12, 2017 |
| International Class | 036 - Insurance; financial affairs; monetary affairs; real estate affairs. |
| US Class Codes | 100, 101, 102 |
| Class Status Code | 2 - Sec. 8 - Entire Registration |
| Class Status Date | Friday, March 29, 2024 |
| Primary Code | 036 |
| First Use Anywhere Date | Friday, May 12, 2017 |
| First Use In Commerce Date | Friday, May 12, 2017 |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 2 - Sec. 8 - Entire Registration |
| Class Status Date | Friday, March 29, 2024 |
| Primary Code | 042 |
| First Use Anywhere Date | Friday, May 12, 2017 |
| First Use In Commerce Date | Friday, May 12, 2017 |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 2 - Sec. 8 - Entire Registration |
| Class Status Date | Friday, March 29, 2024 |
| Primary Code | 044 |
| First Use Anywhere Date | Friday, May 12, 2017 |
| First Use In Commerce Date | Friday, May 12, 2017 |
| Party Name | Intermountain Insights, LLC |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Salt Lake City, UT 84111 |
| Party Name | Intermountain Insights, LLC |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Salt Lake City, UT 84111 |
| Party Name | Intermountain Insights, LLC |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Salt Lake City, UT 84111 |
| Event Date | Event Description |
| Friday, March 29, 2024 | CANCELLED SEC. 8 (6-YR) |
| Monday, September 19, 2022 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED |
| Tuesday, September 19, 2017 | REGISTERED-PRINCIPAL REGISTER |
| Friday, August 18, 2017 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| Thursday, August 17, 2017 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| Tuesday, August 1, 2017 | STATEMENT OF USE PROCESSING COMPLETE |
| Friday, June 30, 2017 | USE AMENDMENT FILED |
| Tuesday, August 1, 2017 | DIVISIONAL PROCESSING COMPLETE |
| Friday, June 30, 2017 | DIVISIONAL REQUEST RECEIVED |
| Friday, July 21, 2017 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Friday, June 30, 2017 | TEAS REQUEST TO DIVIDE RECEIVED |
| Friday, June 30, 2017 | TEAS STATEMENT OF USE RECEIVED |
| Tuesday, January 3, 2017 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, November 8, 2016 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, November 8, 2016 | PUBLISHED FOR OPPOSITION |
| Wednesday, October 19, 2016 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, October 4, 2016 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
| Tuesday, September 27, 2016 | ASSIGNED TO LIE |
| Wednesday, September 14, 2016 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, September 14, 2016 | EXAMINER'S AMENDMENT ENTERED |
| Wednesday, September 14, 2016 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Wednesday, September 14, 2016 | EXAMINERS AMENDMENT E-MAILED |
| Wednesday, September 14, 2016 | EXAMINERS AMENDMENT -WRITTEN |
| Wednesday, September 7, 2016 | ASSIGNED TO EXAMINER |
| Thursday, July 14, 2016 | TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED |
| Thursday, July 14, 2016 | TEAS VOLUNTARY AMENDMENT RECEIVED |
| Wednesday, July 6, 2016 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Monday, July 4, 2016 | NEW APPLICATION ENTERED |